Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tissue Transplantation01:24

Tissue Transplantation

343
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
343
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

807
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
807
Pneumothorax-II01:27

Pneumothorax-II

126
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
126

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Incidence, predictors and outcomes following primary graft dysfunction after cardiac transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Compassionate Use of Hypothermic Oxygenated Perfusion for Donor Hearts: Extending the Boundaries of Heart Recipient Complexity in Heart Transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Heart recipient outcomes following transplantation of donor hearts with impaired versus normal function: a study protocol for IMPROVED Heart, a prospective multicentre observational study.

BMJ open·2026
Same author

Geographical, institutional and workplace variability in genetic evaluation, screening practices, multidisciplinary care, and lung transplantation management for familial interstitial lung disease.

BMC pulmonary medicine·2026
Same author

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2026 Annual Pediatric Heart Transplantation Report, Trends and Post-transplant Outcomes by Recipient Sex.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Menopausal hormone therapy prescription and ovary-sparing surgery in women with pre-menopausal endometrial cancer: a Swedish PremEnCa study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

相关实验视频

Updated: Jun 12, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

823

肺移植后的恶性瘤

Caroline Stenman1, Andreas Wallinder1,2, Erik Holmberg3,4

  • 1Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.

Transplant international : official journal of the European Society for Organ Transplantation
|September 24, 2024
PubMed
概括

肺移植接受者在手术后面临的新癌症发病风险明显更高. 然而,肺移植前的癌症史并没有对长期生存结果产生负面影响.

关键词:
癌症 癌症 癌症 癌症 癌症队列研究是一项队列研究.流行病学流行病学心脏移植心脏移植手术免疫抑制是一种免疫抑制.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.9K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

相关实验视频

Last Updated: Jun 12, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

823
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.9K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

科学领域:

  • 医学研究 医学研究
  • 在瘤学瘤学.
  • 移植免疫学 移植免疫学

背景情况:

  • 肺移植 (LTx) 是对末期肺病的关键干预.
  • 了解先前有癌症史的患者移植后癌症风险和结果至关重要.

研究的目的:

  • 为了确定肺移植后恶性瘤的发生率.
  • 评估肺移植接受者与移植前癌症诊断的长期存活率.

主要方法:

  • 追溯队列研究,包括614名肺移植接受者 (1990-2016).
  • 癌症发病率通过与瑞典癌症登记处和死亡原因登记处的联系来确定.
  • 标准化发病率 (SIR) 计算用于将癌症风险与一般人群进行比较.

主要成果:

  • 在LTx后诊断了159种恶性瘤,与普通人群相比,风险增加了5.6倍.
  • 最常见的LTx后癌症:非黑色素瘤皮肤癌 (SIR 76.5),非霍奇金淋巴瘤 (SIR 23.5) 和肺癌 (SIR 8.89).
  • 接受者与没有癌症病史之间的整体存活率没有显著差异 (p=0.56).

结论:

  • 肺移植接受者患上后续癌症的风险大幅增加.
  • 在经过精心挑选的肺移植候选人中,先前的癌症诊断似乎不会对长期生存产生不利影响.